Episode 47: Interview with Katrina Firlik, M.D., Co-Founder & Chief Medical Officer of HealthPrize Technologies, Neurosurgeon, and Author

In this episode Maxwell Cooper, M.D. interviews Katrina Firlik, M.D., Co-Founder and Chief Medical Officer of HealthPrize Technologies, a digital health company developing a web-based platform to improve patient compliance in an engaging way to provide better outcomes. Dr. Firlik is also a neurosurgeon and the author of the non-fiction book Another Day in The Frontal Lobe. Dr. Firlik tells the listeners of her innovation journey that began as a practicing neurosurgeon and how she transitioned to become a full-time medtech entrepreneur. Dr. Firlik discusses the early days of Co-Founding HealthPrize Technologies, raising capital from investors, building a great team, and marketing a novel solution. Dr. Firlik gives an overview of her role as Chief Medical Officer and how conducting clinical research with HealthPrize's platform has been critical to demonstrating efficacy and improved long-term outcomes. Lastly, Dr. Firlik reflects on her diverse experiences and provides advice for re-inventing yourself and tackling a steep learning curve.

*Views expressed in this podcast are those of the individuals, not their respective institutions

Thank you to our sponsor Doc2Doc Lending, the Personal Lending platform designed for Doctors, by Doctors. Check out https://doc2doclending.com/davinci to learn more today.

Katrina Firlik, M.D.
Co-Founder & Chief Medical Officer, HealthPrize Technologies
Author of Another Day in The Frontal Lobe, A Brain Surgeon Exposes Life on the Inside
Website: https://katrinafirlik.com/
HealthPrize Technologies: https://healthprize.com/
Epilepsy Surgery Fellowship, Yale University
Neurosurgery Residency, University of Pittsburgh Medical Center
M.D., Case Western University of School of Medicine
B.S., Cornell University

50% Complete

Two Step

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.